Detalhe da pesquisa
1.
Understanding potential barriers and enablers to a perioperative early phase cell therapy trial.
Cytotherapy;
24(6): 629-638, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35396169
2.
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men.
Transfusion;
62(8): 1571-1582, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35834537
3.
Addressing feasibility challenges to delivering intradialytic exercise interventions: a theory-informed qualitative study.
Nephrol Dial Transplant;
37(3): 558-574, 2022 02 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34415351
4.
Building a Platform for Meaningful Patient Partnership to Accelerate "Bench-to-Bedside" Translation of Promising New Therapies.
Healthc Q;
24(SP): 74-79, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35467515
5.
So You Want to Give Stem Cells to Babies? Neonatologists and Parents' Views to Optimize Clinical Trials.
J Pediatr;
210: 41-47.e1, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31005276
6.
Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol.
Pilot Feasibility Stud;
7(1): 75, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33741062
7.
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Trials;
22(1): 230, 2021 Mar 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33766105
8.
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.
BMJ Open;
11(3): e043929, 2021 03 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33741670
9.
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
Res Involv Engagem;
6: 61, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33072399
10.
What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study.
BMJ Open;
10(3): e034354, 2020 03 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32198301